BioHealth News Archive

23andMe’s Consumer DNA Data Gold Mine Is Starting To Pay Off – Fast Company

23andMe’s Consumer DNA Data Gold Mine Is Starting To Pay Off – Fast Company

After decades of inconclusive results, researchers backed by Pfizer and Massachusetts General Hospital revealed that they had identified several genetic markers associated with depression…

Read More
20 Executives Selected for Women in Bio’s First Boardroom Ready Class

20 Executives Selected for Women in Bio’s First Boardroom Ready Class

Twenty accomplished female life sciences executives will comprise the first ever cohort of Women In Bio’s Boardroom Ready program, the organization announced today. The…

Read More
Can a Supercomputer Suggest the Best Cancer Treatment? – Scientific American

Can a Supercomputer Suggest the Best Cancer Treatment? – Scientific American

In 2011, a supercomputer won $1 million on Jeopardy! In 2016, that same supercomputer is tackling a challenge quantified not in millions of dollars…

Read More
FDA Grants Tentative Approval for Trokendi XR in Migraine Prophylaxis – MPR

FDA Grants Tentative Approval for Trokendi XR in Migraine Prophylaxis – MPR

Supernus announced that the Food and Drug Administration (FDA) has granted tentative approval to the supplemental New Drug Application (sNDA) proposing a label expansion…

Read More
Precision Medicine’s Top 50 Influencers revealed!

Precision Medicine’s Top 50 Influencers revealed!

Precision Medicine is gathering pace, driven by leaders from across healthcare, academia, Big Pharma, government, technology innovators and more. In the past year the…

Read More
New Enterprise Associates ups its investment in cyber-threat detection – The Washington Post

New Enterprise Associates ups its investment in cyber-threat detection – The Washington Post

Chevy Chase venture fund New Enterprise Associates upped its bet on ThreatQuotient, a Reston-based cybersecurity analytics start-up, in a $12 million investment announced Tuesday.…

Read More
GSK tops list of businesses which ‘change the world’

GSK tops list of businesses which ‘change the world’

The company, which employs more than 300 people at its plant in Ulverston, was praised for its work helping tackle diseases in both the…

Read More
Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today a $14.4 million grant from the U.S. National…

Read More
University of Maryland receives $14.4 million for HIV study – Baltimore Business Journal

University of Maryland receives $14.4 million for HIV study – Baltimore Business Journal

The Institute of Human Virology at the University of Maryland School of Medicine received a $14.4 million grant for HIV research. The grant, awarded…

Read More
New NHLBI SBIR contract solicitation – SBIR.gov

New NHLBI SBIR contract solicitation – SBIR.gov

New treatments are needed for severe asthmatics who do not respond to standard therapy with inhaled steroids, especially those with a “type 2 low”…

Read More
NCI SBIR Briefing

NCI SBIR Briefing

This free event brought to you by BioHealth Innovation is to gather interested small businesses seeking funding from the NCI SBIR grants program. Connect…

Read More
Jonathan Aberman: The one void that could slow our cybersecurity dreams – The Washington Post

Jonathan Aberman: The one void that could slow our cybersecurity dreams – The Washington Post

More and more people agree: cybersecurity is in our region’s DNA and can continue to be a boom for greater Washington. But venture capital…

Read More
Biotechnology Ranks No. 2 on Venture Capital List

Biotechnology Ranks No. 2 on Venture Capital List

Venture capital (VC) financing fuels our future by investing in small, early-stage companies and projects that may be destined to become the next Apple…

Read More
Cameo: Ron Daniels – Baltimore magazine

Cameo: Ron Daniels – Baltimore magazine

You came to Hopkins in 2009 and now your contract has been extended through 2024. That’s a long time! The board invited me to…

Read More
The ‘Cancer Moonshot’ May Succeed — If We Don’t Weaken Patent Protections [Opinion]

The ‘Cancer Moonshot’ May Succeed — If We Don’t Weaken Patent Protections [Opinion]

Joe Biden's cancer moonshot might not be as far-fetched as you think. Why? Because multiple U.S. agencies recently took steps to make the cancer moonshot a reality by further strengthening patent…

Read More